Search Within

Miteshkumar V Patel

Formats
  1. Journal Article (14)
  2. Meeting Abstract (3)
Groups
  1. Sloan Kettering Institute Postdocs (15)
  2. Department of Medicine (12)
  3. GSK Faculty (12)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (11)
  5. Radiology, Department of (11)
  6. Solid Tumor Oncology Division (11)

More Groups

People
  1. Andrea Cercek Hanjis (8)
  2. Hong-Fen Guo (8)
  3. Luis Diaz (8)
  4. Nai-Kong Cheung (8)
  5. Sarah Cheal (8)
  6. Steven Larson (8)

More People

Years
  1. 2025 (5)
  2. 2024 (2)
  3. 2023 (1)
  4. 2022 (2)
  5. 2021 (1)
  6. 2020 (2)

More Years

Publications
  1. Journal of Nuclear Medicine (3)
  2. Clinical Cancer Research (2)
  3. Journal of Clinical Oncology (2)
  4. New England Journal of Medicine (2)
  5. Theranostics (2)
  6. Bioconjugate Chemistry (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. Society of Nuclear Medicine (3)
  3. American Society of Clinical Oncology (2)
  4. Ivyspring International Publisher (2)
  5. Massachusetts Medical Society (2)
  6. Oxford University Press (2)

More Publishers

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A self-assembling and disassembling (SADA) bispecific antibody (BsAb) platform for curative two-step pretargeted radioimmunotherapy
    Journal Article

    Santich, B. H.; Cheal, S. M.; Ahmed, M.; McDevitt, M. R.; Ouerfelli, O.; Yang, G.; Veach, D. R.; Fung, E. K.; Patel, M.; Burnes Vargas, D.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Alpha radioimmunotherapy using (225)Ac-proteus-DOTA for solid tumors – Safety at curative doses
    Journal Article

    Cheal, S. M.; McDevitt, M. R.; Santich, B. H.; Patel, M.; Yang, G.; Fung, E. K.; Veach, D. R.; Bell, M.; Ahad, A.; Burnes Vargas, D.; more...
    Theranostics (2020)

    Fulltext@MSK | Save
  • An N-acetylgalactosamino dendron-clearing agent for high-therapeutic-index DOTA-hapten pretargeted radioimmunotherapy
    Journal Article

    Cheal, S. M.; Patel, M.; Yang, G.; Veach, D.; Xu, H.; Guo, H. F.; Zanzonico, P. B.; Axworthy, D. B.; Cheung, N. K. V.; Ouerfelli, O.; more...
    Bioconjugate Chemistry (2020)

    Fulltext@MSK | Save
  • Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma
    Journal Article

    Cheal, S. M.; Xu, H.; Guo, H. F.; Patel, M.; Punzalan, B.; Fung, E. K.; Lee, S. G.; Bell, M.; Singh, M.; Jungbluth, A. A.; more...
    Theranostics (2018)

    Fulltext@MSK | Save
  • Curative multicycle radioimmunotherapy monitored by quantitative SPECT/CT-based theranostics, using bispecific antibody pretargeting strategy in colorectal cancer
    Journal Article

    Cheal, S. M.; Fung, E. K.; Patel, M.; Xu, H.; Guo, H. F.; Zanzonico, P. B.; Monette, S.; Wittrup, K. D.; Cheung, N. K. V.; Larson, S. M.
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • Comparative efficacy and toxicity of (177)Lu- vs (90)Y-theranostic anti-HER2/anti-DOTA(metal) pretargeted radioimmunotherapy (anti-HER2 DOTA-PRIT) of HER2-expressing breast cancer xenografts with curative intent
    Meeting Abstract

    Cheal, S.; Fung, E.; Xu, H.; Guo, H. F.; Patel, M.; Bell, M.; Kalidindi, T.; Punzalan, B.; Zanzonico, P.; Wittrup, K.; more...
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • ZCCHC17 is a potential driver of synaptic dysfunction in Alzheimer's Disease
    Meeting Abstract

    Teich, A.; Tomljanovic, Z.; Patel, M.
    Journal of Neuropathology and Experimental Neurology (2016)

    Fulltext@MSK | Save